RAS President, Professor Michael Rowan-Robinson, said: “We are aiming to publish books of a wide variety of types and levels, but all at the highest scientific standard. We are primarily interested in exploiting the Society’s assets – its members, its archives, its meetings – to advance our sciences through all kinds of book publishing. We chose Springer because it is an international publisher with a range of imprints and series that can well present the kinds of books we have in mind, and because it is interested in moving forward imaginatively with us into the era of electronic publishing.”
Hubertus von Riedesel, Vice President, Publishing, Physical Sciences and Engineering at Springer, said, “Springer is proud to work with such an esteemed organization as the Royal Astronomical Society with its long history of high-quality publications. Our publishing strategy is to maximize circulation, visibility, and access to academic information. This overlaps with the main goals of the RAS – maximum dissemination of the research results published by astronomers worldwide.”
The agreement will strengthen Springer’s existing book program in this field, which comprises about 150 titles published annually. The partnership enables the RAS to expand its publishing portfolio, which currently consists of three learned journals producing 25,000 pages per year, two-thirds of which originate from outside the UK. The first two books are already in preparation and will review research into white dwarf stars and the ‘many-body problem’ – how stars, planets and galaxies interact through gravitation.
Founded in 1820, the Royal Astronomical Society has more than 3,000 members in 73 countries. It is the UK’s leading professional body for astronomy and astrophysics, geophysics, solar and solar-terrestrial physics and planetary sciences. The RAS organizes scientific meetings, publishes international research and review journals, awards grants and prizes, maintains an extensive library, supports educational activities and lobbies government.
Springer is the second-largest publisher worldwide in the science, technology, and medicine (STM) sector and publishes on behalf of more than 300 academic associations and professional societies. It is the world’s leading book publisher in astronomy. Springer is part of Springer Science+Business Media, one of the world’s leading suppliers of scientific and specialist literature. The group owns 70 publishing houses, together publishing a total of 1,450 journals and more than 5,000 new books a year. The group operates in over 20 countries in Europe, the USA, and Asia, and has some 5,000 employees.
David Elliott | alfa
New type of low-energy nanolaser that shines in all directions
18.12.2018 | Eindhoven University of Technology
NASA research reveals Saturn is losing its rings at 'worst-case-scenario' rate
18.12.2018 | NASA/Goddard Space Flight Center
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy